These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28779354)
61. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system. Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035 [No Abstract] [Full Text] [Related]
62. Retrospective analysis of a Bi-National Colorectal Cancer Audit to characterize stage II colon cancer patients who were offered adjuvant chemotherapy. Cooper EA; Buxey KN; Maslen BJ; Muhlmann M ANZ J Surg; 2020 Jun; 90(6):1136-1140. PubMed ID: 32072761 [TBL] [Abstract][Full Text] [Related]
63. Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy. Abdel-Misih SR; Wei L; Benson AB; Cohen S; Lai L; Skibber J; Wilkinson N; Weiser M; Schrag D; Bekaii-Saab T J Natl Compr Canc Netw; 2016 Dec; 14(12):1528-1534. PubMed ID: 27956537 [TBL] [Abstract][Full Text] [Related]
64. [Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy]. Zhou ZG; Pan ZZ; Wan DS; Li LR; Wu XJ; Ding PR; Lin JZ; Peng ZH Ai Zheng; 2009 Sep; 28(9):908-12. PubMed ID: 19728905 [TBL] [Abstract][Full Text] [Related]
65. [Surgical treatment for colorectal cancer with simultaneous hepatic metastasis]. Zhao DB; Shan Y; Wang CF; Wu JX; Shao YF; Zhao P Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):552-4. PubMed ID: 18069642 [TBL] [Abstract][Full Text] [Related]
67. Multidisciplinary decisions in breast cancer: does the patient receive what the team has recommended? Rajan S; Foreman J; Wallis MG; Caldas C; Britton P Br J Cancer; 2013 Jun; 108(12):2442-7. PubMed ID: 23736032 [TBL] [Abstract][Full Text] [Related]
68. Evaluation of a pre-operative staging protocol in the management of colorectal carcinoma. Griffiths EA; Browell DA; Cunliffe WJ Colorectal Dis; 2005 Jan; 7(1):35-42. PubMed ID: 15606582 [TBL] [Abstract][Full Text] [Related]
69. [The present status of CapeOX as adjuvant chemotherapy for colorectal cancer]. Ishii K; Kanamoto A; Miyanaga S; Noto M; Takeda T; Tani T; Yagi M Gan To Kagaku Ryoho; 2015 Mar; 42(3):319-22. PubMed ID: 25812500 [TBL] [Abstract][Full Text] [Related]
70. Impact of a Multidisciplinary Team Approach for Managing Advanced and Recurrent Colorectal Cancer. Jung SM; Hong YS; Kim TW; Park JH; Kim JH; Park SH; Kim AY; Lim SB; Lee YJ; Yu CS World J Surg; 2018 Jul; 42(7):2227-2233. PubMed ID: 29282505 [TBL] [Abstract][Full Text] [Related]
71. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. Park YJ; Park KJ; Park JG; Lee KU; Choe KJ; Kim JP World J Surg; 1999 Jul; 23(7):721-6. PubMed ID: 10390594 [TBL] [Abstract][Full Text] [Related]
72. Improved survival for rectal cancer compared to colon cancer: the four cohort study. Buchwald P; Hall C; Davidson C; Dixon L; Dobbs B; Robinson B; Frizelle F ANZ J Surg; 2018 Mar; 88(3):E114-E117. PubMed ID: 27618786 [TBL] [Abstract][Full Text] [Related]